ID.FLOW Trademark

Trademark Overview

On Tuesday, August 24, 2021, a trademark application was filed for ID.FLOW with the United States Patent and Trademark Office. The USPTO has given the ID.FLOW trademark a serial number of 79324177. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by ImmuNeed AB. The ID.FLOW trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research within the area of biological pharmaceuticals; pharmaceutical research services, namely, research services within pre-clinical research for detection of blood and analyses of pharmaceutical substances in the human body; pharmaceutical research services, namely, research services within the preclinical stage providing evidence regarding the safety and efficacy of drug candidates; pharmaceutical research services, namely, analysis of pharmaceutical substances; pharmaceutical research services, namely, analysis of production and adoption of pharmaceuticals
id.flow

General Information

Serial Number79324177
Word MarkID.FLOW
Filing DateTuesday, August 24, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6914950
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesResearch within the area of biological pharmaceuticals; pharmaceutical research services, namely, research services within pre-clinical research for detection of blood and analyses of pharmaceutical substances in the human body; pharmaceutical research services, namely, research services within the preclinical stage providing evidence regarding the safety and efficacy of drug candidates; pharmaceutical research services, namely, analysis of pharmaceutical substances; pharmaceutical research services, namely, analysis of production and adoption of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmuNeed AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameImmuNeed AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameImmuNeed AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events

Event DateEvent Description
Wednesday, April 19, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 29, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 28, 2023FINAL DISPOSITION PROCESSED
Monday, March 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Friday, November 11, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 27, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, September 5, 2022REFUSAL PROCESSED BY IB
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 5, 2022REFUSAL PROCESSED BY IB
Friday, June 10, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 10, 2022REFUSAL PROCESSED BY MPU
Tuesday, June 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Thursday, May 26, 2022ASSIGNED TO EXAMINER
Saturday, December 4, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 5, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 28, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

flow research pharmaceutical services namely within substances analysis pharmaceuticals safety regarding